September 26, 2022

The Fall 2022 advocacy blog ‘Considering Clinical Trials’ is now available

September 8, 2022

Press Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

August 23, 2022

Attention CRAs: Travel funds are available for the fall meeting. Apply now.

August 23, 2022

Fall meeting attendance awards are available for minority and minority-focused trainees. Apply now.

August 16, 2022

The August 2022 ‘News from ECOG-ACRIN’ blog is now available

August 10, 2022

President Biden announces his intent to appoint Dr. Monica Bertagnolli as the next NCI director

August 9, 2022

Early-career investigators: Submit an abstract for the 2022 Young Investigator Symposium by Wednesday, 9/7

July 21, 2022

Group co-chairs Peter O’Dwyer and Mitch Schnall commend the selection of Monica Bertagnolli as the next NCI director

July 15, 2022

Ongoing Smoke Free Support Study 2.0 featured in BioMed Central’s Public Health Journal

ECOG-ACRIN Cancer Research Group